Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | en |
| Published: |
Medical Education Cooperation with Cuba
2020
|
| Subjects: | |
| Online Access: | https://www.redalyc.org/articulo.oa?id=437565248014 https://www.redalyc.org/journal/4375/437565248014/ https://www.redalyc.org/journal/4375/437565248014/html/ https://www.redalyc.org/journal/4375/437565248014/437565248014.epub https://www.redalyc.org/journal/4375/437565248014/movil https://doi.org/10.37757/MR2020.V22.N4.4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Early Action, Applied Research & Collaboration to Combat COVID-19: María Guadalupe Guzmán MD PhD DSc Director, Reference Center for Research & Diagnosis, Pedro Kourí Tropical Medicine Institute, Havana Gisele Coutin Conner Gorry Medicina Virologist Dr María Guadalupe Guzmán is recognized as a global leader in dengue research and heads the Pedro Kourí Tropical Medicine Institute’s work as a WHO/PAHO Collaborating Center for the Study of Dengue and Its Vector. The Institute (IPK) was founded in 1937 and is now Cuba’s national reference center for the diagnosis, treatment, control and prevention of communicable diseases. Dr Guzmán is also president of the Cuban Society of Microbiology and Parasitology and directs IPK’s Scientific Council, which is responsible for setting the Institute’s research priorities. A recent h-index analysis found that Dr Guzmán is among the most widely-published and cited Cuban researchers.As part of the National Intersectoral Commission for COVID-19, IPK was integral to the design of Cuba’s COVID-19 Prevention and Control Plan, approved in February 2020, more than a month before the first cases were confirmed in Cuba. This included the three-tiered biosafety training program for frontline health professionals, designed and launched at IPK, which built on the institution’s experience preparing Cuban doctors who served in West Africa with the Henry Reeve Emergency Medical Contingent during the 2014–2016 Ebola outbreak. As of this writing, the Contingent has served in 39 countries fighting COVID-19. Prior to departure, members were trained in biosafety at IPK.Today, IPK conducts COVID-19 testing and research and provides patient care. The institution is supported by an integrated national network of diagnostic laboratories, hospitals and isolation centers. In addition to research related to the clinical evolution and epidemiology of COVID-19, IPK has several studies under way on its diagnosis, pathogenesis, kinetics, immunity and genetics. In July 2020, Dr Guzmán, along with 7 other Cuban specialists, was appointed to the InterAcademy Partnership’s (IAP) COVID-19 Expert Group, a 60-member, multi-disciplinary group comprised of researchers from around the world. The group is designed to promote knowledge sharing and regional and international collaborations concerning the coronavirus using a multisector approach that takes into account the health, social and environmental factors related to the disease. This MEDICC Review interview took place in early July, a few days before the Cuban IAP appointments were announced. 2020 artículo científico 1555-7960 https://www.redalyc.org/articulo.oa?id=437565248014 https://www.redalyc.org/journal/4375/437565248014/ https://www.redalyc.org/journal/4375/437565248014/html/ https://www.redalyc.org/journal/4375/437565248014/437565248014.epub https://www.redalyc.org/journal/4375/437565248014/movil https://doi.org/10.37757/MR2020.V22.N4.4 en http://www.redalyc.org/revista.oa?id=4375 MEDICC Review application/pdf Medical Education Cooperation with Cuba MEDICC Review (Estados Unidos de América) Num.4 Vol.22